EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS. Mediterr J Hematol Infect Dis 2015, 7 (1), e2015058. https://doi.org/10.4084/mjhid.2015.058.